Type 2 diabetes and metformin

Prescrire International

Volumn 23, Issue 154, 2014, Pages 269-272

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROPAMIDE; GLIBENCLAMIDE; GLIPIZIDE; INSULIN; METFORMIN; ROSIGLITAZONE; ANTIDIABETIC AGENT;

CANCER RISK; CARDIOVASCULAR DISEASE; CYANOCOBALAMIN DEFICIENCY; DIABETIC PATIENT; DRUG EFFICACY; GASTROINTESTINAL DISEASE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; KIDNEY FAILURE; LACTIC ACIDOSIS; MACROCYTIC ANEMIA; META ANALYSIS (TOPIC); MONOTHERAPY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PERIPHERAL NEUROPATHY; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; WEIGHT GAIN; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; COMPLICATION; DIABETES MELLITUS, TYPE 2; PATHOPHYSIOLOGY; PROCEDURES;

CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; PRACTICE GUIDELINES AS TOPIC;

EID: 84911951147     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Bennett WL et al. "Evaluation of guideline recom mendations on oral medications for type 2 diabetes mellitus" Ann Intern Med 2012; 156 (1): 27-36.
2. UK Prospective Diabetes Study (UKPDS) Group "Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)" Lancet 1998; 352: 854-865.
3. Prescrire Editorial Staff "Management of type 2 diabetes" Prescrire Int 1999; 8 (43): 147-152.
4. Boussageon R "Metformine dans le diabète de type 2: et si on s'était trompé ?" Presse Méd 2013; 42: 132-133.
5. McCormack J and Greenhalgh T "Seeing what you want to see in randomised controlled trials: versions and perversions of UKPDS data" BMJ2000; 320: 1720-1723.
6. Ewart RM "The case against aggressive treatment of type 2 diabetes: critique of the UK prospective diabetes study" BMJ 2001; 323: 854-858.
7. Prescrire Rédaction "Lectures critiques Prescrire. Exercice No 46: Faire dire à tout prix" Rev Prescrire 2012; 32 (341): 238.
8. Kahn SE et al. "Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy" N Engl J Med 2006; 355 (23): 2427-2443.
9. Lamanna C et al. "Effect of metformin in cardiovascular events and mortality: a meta-analysis of randomized clinical trials" Diabetes Obesity Metab 2011; 13 (3): 221-228.
10. Cryer DR et al. "Comparative outcomes study of metformin intervention versus conventional approach. The Cosmic Approach Study" Diabetes Care 2005; 28 (3): 539-543.
11. Hong Jie et al. "Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease" Diabetes Care 2013; 36 (5): 1304-1311.
12. Moore EM et al. "Increased risk of cognitive impairment in patients with diabetes is associated with metformin" Diabetes Care 2013; 36: 2981-2987.
13. Base de données publiques des médicaments "Fiche info Glucophage 500 mg, comprimé pelliculé", http://base-donnees-publique.medicaments.gouv.fr accessed 20 May 2014: 2 pages.
14. Prescrire Rédaction "4-1-3 Patients sous metformine" Rev Prescrire 2013; 33 (362 suppl. interactions médicamenteuses).
15. Saenz A et al. "Metformin monotherapy for type 2 diabetes mellitus" (Cochrane review) (updated 2003). In: "The Cochrane Library" John Wiley and Sons, Chichester, 2009 issue 1: 138 pages.
16. "Biguanides antidiabetics", "Metformin hydrochloride" In: "Martindale The Complete Drug Reference" "The Pharmaceutical Press, London. www.medicinescomplete.com accessed 3 April 2014: 9 pages + 13 pages.
17. Prescrire Editorial Staff "Metformin: preventable lactic acidosis" Prescrire Int 2007; 16 (87): 19.
18. Prescrire Rédaction "Acidoses lactiques et antirétroviraux" Rev Prescrire 2002; 22 (228): 357-359.
19. Salpeter SR et al. "Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus" (Cochrane review) (updated 2009). In: "The Cochrane Library" John Wiley and Sons, Chichester, 2010 issue 4: 233 pages.
20. Prescrire Rédaction "Peut-on utiliser la metformine en cas d'insuffisance cardiaque ou coronaire ?" Rev Prescrire 2001; 21 (215): 235-236.
21. de Jager J et al. "Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B12 deficiency: randomised placebo controlled study" BMJ 2010; 340: c2181.
22. Prescrire Rédaction "Déficit en vitamine B12 sous metformine" Rev Prescrire 2004; 24 (250): 349.
23. Schrier SL et al. "Etiology and clinical manifestations of vitamin B12 and folate deficiency" (updated March 2014) UpToDate, Waltham; version 22.2: 15 pages
24. Franciosi M et al. "Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review" PloS Med 2013; 8 (8): e71583.
25. Rao AD et al. "Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all-cause mortality? A meta-analysis of observational studies" Diabetes Care 2008; 31 (8): 1672-1678.
26. Boussageon R et al. "Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a metaanalysis of randomised controlled trials" PloS Med 2012; 9 (4): e1001204 : 10 pages.